CD1A, D and E gene polymorphisms in a North African population from Morocco
Anna Aureli1, Khadija Oumhani2, Tiziana Del Beato1
1CNR Institute of Translational Pharmacology, UOS L'Aquila, Italy.
Human Immunology
|May 10, 2016
Summary
This study investigated CD1 gene variations in a Moroccan population, revealing ethnic differences in CD1D and CD1E. Understanding CD1 polymorphism is key for developing new immunotherapies.
Area of Science:
- Immunology
- Human Genetics
Background:
- CD1 molecules present lipids/glycolipids to T and NKT cells, crucial for immune responses.
- Lipid antigen presentation by CD1 is vital in microbial infections.
- Human CD1 genes (CD1A-E) exhibit limited polymorphism.
Purpose of the Study:
- To investigate exon 2 polymorphisms in CD1A, CD1D, and CD1E genes.
- To determine allele, genotype, and haplotype frequencies in a Moroccan population.
- To compare these frequencies with other geographic populations.
Main Methods:
- Genotyping of CD1A, CD1D, and CD1E exon 2.
- Analysis of allele, genotype, and haplotype frequencies.
- Cross-population comparative analysis.
Main Results:
- Confirmed ethnic variations in CD1 gene polymorphism.
- Identified two novel CD1D alleles (CD1D*03, CD1D*04) in the Moroccan population.
- Significant differences observed in CD1D and CD1E frequencies.
Conclusions:
- CD1 polymorphism varies significantly across ethnic groups.
- Novel CD1D alleles highlight population-specific genetic diversity.
- Data supports exploring CD1's role in disease pathogenesis and immunotherapy development.
Related Concept Videos
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
65
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
65
02:32Exon Recombination
4.3K
The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes.
Exon shuffling follows “splice frame rules.” Each exon...
Exon shuffling follows “splice frame rules.” Each exon...
4.3K
01:05Single Nucleotide Polymorphisms-SNPs
19.7K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
19.7K
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
106
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
106
01:27Principles of Pharmacogenetics: Types of Genetic Variants
86
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
86